Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pharmavite Remdex “Achoo” ad campaign

This article was originally published in The Tan Sheet

Executive Summary

Company kicks off "guerilla" ad campaign to support August Remdex launch Jan. 17. Campaign features giant nose mascot named Achoo, who will tour Boston, Chicago, New York, Philadelphia, San Francisco and Washington, D.C. handing out product samples, business cards. On same day, Pharmavite reports its "Wellness Advisor" Web site, which debuted Jan. 15, will feature link to Intramedicine's database of consumer monographs on vitamins, minerals, herbs and nutraceuticals. Database also includes scientific research reviews, drug/nutrient interactions/depletions information and archive of health, wellness articles (1"The Tan Sheet" July 16, 2001, p. 3)...

You may also be interested in...

Pharmavite, Weider Launch Respiratory, Joint Health Supplements

Pharmavite's Remdex Head & Chest Formula dietary supplement, positioned as an "effective and non-drowsy, all natural" alternative to OTC cough/cold remedies, is slated to hit food, drug and mass outlets in August.

Mylan Weighs In On Coronavirus Drug Shortage Concerns

Hours before the US FDA confirmed the first drug shortage due to active pharmaceutical ingredient constraints because of the coronavirus situation in China, generics industry leader Mylan came under pressure about the potential impact on its business. 


Eyes On Pricing As Zolgensma Moves Closer To Japan Market

Government advisory committee gives initial nod to what will become Japan’s most expensive single drug, but reimbursement pricing could come in for close scrutiny.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts